Latest News

Sienna Strengthens its Patent Portfolio 20-Aug-2015

Marking a significant milestone in its commercial growth strategy, Sienna Cancer Diagnostics has.. READ MORE

Dr Holloway Now Permanent CEO 26-Jun-2015

The Sienna board is pleased to announce that Cliff Holloway PhD has accepted the role of permane.. READ MORE

Sienna Enters Research Collaboration With UCLA 09-Jun-2015

In an expansion of their global network of scientific and clinical research partners, Sienna Cancer .. READ MORE

Investor Information

Sienna is a public unlisted company headquartered in Melbourne, Australia. It has recently transitioned from a purely Research and Development company to a true commercial entity with product revenues. The company has approximately 130 shareholders and is governed by an experienced board and management team, Sienna has benefited from over $4M in government grants, significantly bolstering investor contributions and facilitating the progress and growth to date. READ MORE

Research

Sienna’s core activities have historically focused on the clinical translation of biomarkers using novel diagnostic technologies for applications in pathology laboratories. The development of inexpensive, high performing in-vitro diagnostic tests is expected to lead to radical changes in the approach to care and assessment of cancer patients – a change welcomed by clinicians and governments. READ MORE

About Sienna

Sienna is a biotechnology company focussed on the development and commercialisation of novel IVD (in vitro diagnostic) tests. Sienna manufactures individual component products for research institutions and pathology laboratories to use in research or in their own laboratory developed tests. Sienna registered their first product with the FDA in 2014, the Anti-hTERT antibody (SCD-A7). READ MORE

Sienna’s experienced and diverse team was responsible for the launch of the company's first product in the USA, the Anti-hTERT antibody (SCD-A7).

– CEO, Dr Cliff Holloway

Sign up to our newsletter

Contact Sienna

Sienna Cancer Diagnostics

1 Dalmore Drive Scoresby VIC 3179 Australia

Telephone +61 3 8288 2141 Facsimile +61 3 8288 2059